Despite Recursion Pharmaceuticals Inc [RXRX]’s great opportunity, the stock is a bit overvalued
The price of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares last traded on Wall Street rose 3.25% to $8.27. RXRX stock price is now 24.47% away from the 50-day moving average and 2.70% away from the 200-day moving average. The market capitalization of the company currently stands at $3.91B. With the price target of $8, Morgan Stanley […]
Recursion Pharmaceuticals Inc (NASDAQ:RXRX): A Fundamentally Weighted Stock for Long-Term Investors
The stock of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) last traded at $7.58, up 7.21% from the previous session. RXRX stock price is now 14.97% away from the 50-day moving average and -7.55% away from the 200-day moving average. The market capitalization of the company currently stands at $3.27B. With the price target of $8, Morgan Stanley […]
Before You Invest In Recursion Pharmaceuticals Inc (NASDAQ:RXRX), Consider This Metric
Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, up 5.26% to $6.00. RXRX stock price is now -9.13% away from the 50-day moving average and -27.58% away from the 200-day moving average. The market capitalization of the company currently stands at $2.31B. With the price target of $8, Morgan Stanley […]
What is Recursion Pharmaceuticals Inc’s (NASDAQ:RXRX) current market value? Can you beat the fundamentals?
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.18, down -10.64% from the previous session. RXRX stock price is now -7.26% away from the 50-day moving average and -26.41% away from the 200-day moving average. The market capitalization of the company currently stands at $1.58B. With the price target of $8, […]
Before Investing In Recursion Pharmaceuticals Inc (NASDAQ:RXRX), Here Are Some Things To Consider
The stock of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) last traded at $7.58, down -3.32% from the previous session. RXRX stock price is now 14.61% away from the 50-day moving average and -10.12% away from the 200-day moving average. The market capitalization of the company currently stands at $2.17B. With the price target of $8, Morgan Stanley […]
There’s Something Awry at Recursion Pharmaceuticals Inc (NASDAQ:RXRX) Since Share Price Gets Ahead of Fundamentals
The stock of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) last traded at $6.97, up 2.20% from the previous session. RXRX stock price is now 5.81% away from the 50-day moving average and -17.92% away from the 200-day moving average. The market capitalization of the company currently stands at $2.03B. With the price target of $8, Morgan Stanley […]
Stocks like Recursion Pharmaceuticals Inc [RXRX] still have plenty of sunny days ahead
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.32, down -5.39% from the previous session. RXRX stock price is now -5.16% away from the 50-day moving average and -26.17% away from the 200-day moving average. The market capitalization of the company currently stands at $1.84B. With the price target of $8, […]
The most important numbers to know about Recursion Pharmaceuticals Inc (NASDAQ:RXRX)
The stock of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) last traded at $6.36, up 0.47% from the previous session. RXRX stock price is now -5.21% away from the 50-day moving average and -26.68% away from the 200-day moving average. The market capitalization of the company currently stands at $1.85B. With the price target of $8, Morgan Stanley […]
There’s Still Time to Buy Recursion Pharmaceuticals Inc (NASDAQ:RXRX) Stock
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.62, up 7.12% from the previous session. RXRX stock price is now -0.95% away from the 50-day moving average and -25.40% away from the 200-day moving average. The market capitalization of the company currently stands at $1.93B. With the price target of $8, […]
Recursion Pharmaceuticals Inc (RXRX) – it’s time to buy. Check out key Indicators
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.15, down -4.50% from the previous session. RXRX stock price is now -8.73% away from the 50-day moving average and -31.02% away from the 200-day moving average. The market capitalization of the company currently stands at $1.77B. With the price target of $8, […]
